| 1 |
27562137 | The metronomic therapy with prednisone, etoposide, and cyclophosphamide reduces the serum levels of VEGF and circulating endothelial cells and improves response rates and progression-free survival in patients with relapsed or refractory non-Hodgkin's lymphoma. | 2016 Oct |
2 |
| 2 |
25607114 | Resistance of SMMC-7721 hepatoma cells to etoposide in hypoxia is reversed by VEGF inhibitor. | 2015 May |
5 |
| 3 |
25928457 | A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis. | 2015 Apr 17 |
1 |
| 4 |
22993597 | Inhibition of tumor angiogenesis by oral etoposide. | 2010 Sep |
2 |
| 5 |
19794965 | A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. | 2009 Oct |
4 |
| 6 |
18494554 | A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA. | 2008 May 20 |
2 |
| 7 |
16875555 | [The effect of on VEGF-C cDNA transfection on NB4 cell proliferation, differentiation and resistance to apoptosis]. | 2006 Apr |
1 |
| 8 |
16103078 | A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. | 2005 Aug 15 |
1 |
| 9 |
9850095 | Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. | 1998 Dec 1 |
1 |
| 10 |
21533381 | Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients. | 1997 Feb |
1 |